In breast cancer, cytoplasmic HMGB1 expression was associated with TIL levels, but nuclear HMGB1 expression was not associated with TIL levels, and neither cytoplasmic nor nuclear expression of HMGB1 showed prognostic significance in triple negative breast cancer (TNBC) [42]. This evidence concerns the gene HMGB1 and breast carcinoma.